AI low-dose CT, proven performance in multinational clinical trials
2022-09-20
AI low-dose CT, proven performance in multinational clinical trials
The artificial intelligence (AI) low-dose CT technology developed in Korea has proven its performance in the first multinational clinical trial.
Join Us at Arab health 2025 and Experience the Difference!
ClariPi will be at Arab health Jan 27-30, 2025! If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!
